An increased circulating blood volume does not prevent hypotension after pheochromocytoma resection

Takehiko Iijima1, Toshiyuki Takagi, Yasuhide Iwao

  • 1Department of Anesthesiology, Kyorin University School of Medicine, Tokyo, Japan. iijmt@kyorin-u.ac.jp

Insights

Preoperative alpha-blocker therapy in pheochromocytoma patients expands circulating blood volume (CBV), but this expansion is linked to lower post-resection blood pressure. Pulse dye-densitometry aids in managing hypotension by monitoring CBV and cardiac output (CO).

Area of Science:

  • Cardiovascular Physiology
  • Endocrinology
  • Surgical Monitoring

Background:

  • Pheochromocytoma is a tumor causing significant hemodynamic instability.
  • Managing blood pressure and volume in pheochromocytoma patients perioperatively is critical.
  • Novel monitoring techniques are needed to assess circulating blood volume (CBV) and cardiac output (CO) in these patients.

Purpose of the Study:

  • To investigate the relationship between CBV and post-resection hypotension in pheochromocytoma patients.
  • To evaluate the utility of pulse dye-densitometry in monitoring CBV and CO during pheochromocytoma resection.
  • To determine if preoperative alpha-blocker therapy affects post-resection hemodynamics.

Main Methods:

  • A case control study involving seven pheochromocytoma patients.
  • Monitoring CBV and CO using pulse dye-densitometry before, during, and after alpha-blocker therapy and tumor resection.
  • Quantifying the effect of alpha-blocker therapy on CBV expansion.

Main Results:

  • Alpha-blocker therapy significantly increased CBV from 72.0 ± 10.0 mL/kg to 83.4 ± 12.2 mL/kg (P < 0.001).
  • A significant inverse relationship was observed between the increase in CBV after alpha-blockade and post-resection blood pressure.
  • CBV expansion did not preclude post-resection hypotension.

Conclusions:

  • Expansion of CBV with alpha-blockers is associated with lower post-resection blood pressure in pheochromocytoma patients.
  • Preoperative blood volume expansion does not prevent hypotension after tumor resection.
  • Pulse dye-densitometry is a valuable tool for simultaneous CO and CBV monitoring, aiding in the management of volume resuscitation and catecholamine use.
Abstract

Related Concept Videos

Alterations in Blood Pressure01:30

Alterations in Blood Pressure

Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Adrenergic Antagonists: Pharmacological Actions of &#593;-Receptor Blockers01:22

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Heart Failure Drugs: &#946;-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...